The 7 analysts offering 12-month price forecasts for Haemonetics Corp have a median target of 100.00, with a high estimate of 115.00 and a low estimate of 88.00. The median estimate represents a +20.47% increase from the last price of 83.01.
The current consensus among 8 polled investment analysts is to Buy stock in Haemonetics Corp. This rating has held steady since September, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share $0.71
Reporting Date May 09
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.